64 Views | 35 Downloads
J. Stoddard, Department of Health and Human Services, Section on Bipolar Spectrum Disorders, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, 9000 Rockville Pike MSC-2670, Building 15K, Bethesda, MD 20892-2670, USA. Email: joel.stoddard@nih.gov
We would like to thank the participants and families who were involved in this study, and the staff of the Emotion and Development Branch at the NIMH.
C.Z. is listed as a coinventor on a patent for the use of ketamine and its metabolites in major depression. C.Z. has assigned his rights in the patent to the US government but will share a percentage of any royalties that may be received by the government. All other authors have no conflicts of interest or outside financial support to report.
This research was supported by the Intramural Research Program of the NIMH, and it was conducted under projects ZIA-MH002778 (clinical protocol ) and ZIA-MH002786 (clinical protocol ).